acebrophylline / Generic mfg. - LARVOL DELTA

Effectiveness and tolerability of acebrophylline in patients with chronic obstructive pulmonary disease: a real-world retrospective study from electronic medical records (ERS 2025) - No abstract available

Real-world • Real-world evidence • Retrospective data • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

CARE: Combination of Acetylcysteine and Acebrophylline in Moderate to Severe Asthma and COPD Patients. (PubMed, J Asthma Allergy) - "The combination of N-acetylcysteine and acebrophylline improves QoL in moderate to severe COPD patients and FEV1 in both COPD and asthma patients with a favorable safety and tolerability profile. The combination appears safe and effective for managing obstructive airway disease."

Journal • Asthma • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases

Evolution of large stokes shift and non-radiative energy transfer phenomenon in sustainable blue-fluorescent CQDs upon subnanomolar detection of Acebrophylline. (PubMed, Spectrochim Acta A Mol Biomol Spectrosc) - "In vitro anti-inflammatory activity and in vivo bioimaging studies on zebrafish were also performed. This study highlights several advantages, including a cost-effective and eco-friendly approach for healthcare applications."

Journal • Respiratory Diseases

Simultaneous bioanalysis and pharmacokinetic interaction study of Acebrophylline, Levocetirizine and Pranlukast in Sprague Dawley rat. (PubMed, Biomed Chromatogr) - "The analytes were stable in benchtop (8 h), freeze-thaw (3 cycles), autosampler (8 h) and dry extract (-80°C for 48 h) stability study. The statistical result of the pharmacokinetic study in Sprague-Dawley rats showed a significant change in pharmacokinetic parameters for PRN upon co-administration of the three drugs."

Journal • PK/PD data • Preclinical